ISRCTN18337380
Completed
未知
Evaluation of the clinical and cost effectiveness of Short-term Integrated Palliative Care Services (SIPC) to OPTimise CARE for people with advanced long-term Neurological conditions (OPTCARE Neuro)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Topic: Dementias and neurodegeneration, Neurological disorders
- Sponsor
- King's College London
- Enrollment
- 350
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32857151/ results (added 02/09/2020) 2017 Other publications in https://pubmed.ncbi.nlm.nih.gov/28774963/ (added 15/02/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32902934/ (added 15/02/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adults (aged 18 years or over) severely affected by advanced or progressive stages of the long\-term neurological conditions (LTNCs) of either\*:
- •1\.1\. Multiple Sclerosis (MS) \- patients with either aggressive relapsing disease with rapid development of fixed disability or those with advanced primary or secondary progressive disease, often with limitation in a number of areas including gait and upper limb function. We do not define referral based on disability but would expect most patients to have an Expanded Disability Status Scale (EDSS) of at least 7\.5
- •1\.2\. Parkinsonism \& related disorders (PRDs) i.e.
- •1\.2\.1\. Idiopathic Parkinson’s Disease (IPD), Hoehn and Yahr (H\&Y) stages 4\-5 OR
- •1\.2\.2\. Progressive Supranuclear Palsy (PSP) Hoehn and Yahr (H\&Y) stages 3\-5 OR
- •1\.2\.3\. Multiple System Atrophy (MSA) \- Hoehn and Yahr (H\&Y) stages 3\-5
- •1\.3\. Motor Neurone Disease (MND) all stages
- •2\. Who are deemed (by referring/usual care clinicians) to have:
- •2\.1\. An unresolved symptom (e.g. pain or another symptom) which has not responded to usual care
- •2\.2\. AND at least one of the following: unresolved other symptoms (e.g. breathlessness, nausea/vomiting, spasticity, fatigue); cognitive problems; complex psychological (depression, anxiety, loss, family concerns), communication/information problems and/or complex social needs.
Exclusion Criteria
- •Patients who meet the inclusion criteria but:
- •1\. Are already receiving specialist palliative care
- •2\. Lack capacity and have no family member, friend or informal caregiver who is willing and available to complete questionnaires about their own and the patient’s symptoms and circumstances
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The ACL SNNAP Trial: ACL surgery necessity in non acute patientsSpecialty: Musculoskeletal disorders, Primary sub-specialty: Elective orthopaedic surgeryUKCRC code/ Disease: Musculoskeletal/ Other disorders of the musculoskeletal system and connective tissueMusculoskeletal DiseasesAnterior cruciate ligament deficiencyISRCTN10110685niversity of Oxford316
Completed
Not Applicable
Comparison of the efficacy, tolerance and cost of Algostéril vs Negative Pressure Therapy in preparation for skin grafting following surgical excisioSurgical removal with a granulation phase before a skin graft supported in restorative, reconstructive and plastic surgery serviceSurgerySkin graftISRCTN60292377aboratoires Brothier95
Completed
Not Applicable
Clozapine in the treatment of borderline personality disorder. The CALMED study.ISRCTN18352058Imperial College of Science, Technology and Medicine29
Completed
Not Applicable
Effectiveness of the run-a-mile interventioObesity prevention, physical activityNutritional, Metabolic, EndocrineISRCTN12698269niversity of Birmingham2,280
Completed
Not Applicable
ens replacement planning in patients with cataracts and corneal astigmatism using the iTrace programCataracts with corneal astigmatismEye DiseasesISRCTN94956424Shanxi Eye Hospital63